SCHEMBL30023908

SCHEMBL30023908

O=C(O)c1cc2ccccc2c(Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
MEN1 O00255 1/20 0.50
CYP1A2 P05177 1/20 0.50
GLA P06280 1/20 0.50
CYP2C19 P33261 1/20 0.50
KMT2A Q03164 1/20 0.50
ALOX15 P16050 4/20 0.46
IGFBP3 P17936 4/20 0.44
MGAM O43451 1/20 0.43
TSHR P16473 2/20 0.42
ACMSD Q8TDX5 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NR4A1 P22736 1/20 0.41
NR4A2 P43354 1/20 0.41
NR4A3 Q92570 1/20 0.41
GPR35 Q9HC97 2/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990776 1.00 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL3281702 0.80 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL4768998 0.79 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL9327979 0.79 IGFBP3 (0.52) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL6990584 0.78 EGFR (0.56) ALDH1A1HPGDMEN1CYP1A2GLA
SCHEMBL6981683 0.78 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL31165745 0.78 MEN1 (0.55) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL1202533 0.78 ALDH1A1 (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL30420994 0.78 ALDH1A1 (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1
SCHEMBL29883306 0.78 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115397822-A CBP/EP300 inhibitors and uses thereof 南京药石科技股份有限公司 2022-11-25 CN disclosed